Drug profile · INN
trazodone hydrochloride
TRAZODONE HYDROCHLORIDE
trazodone hydrochloride (TRAZODONE HYDROCHLORIDE) is a serotonin 2a (5-ht2a) receptor antagonist. Associated with Quantum Biopharma. Route of administration: oral. Current US regulatory status: approved.
Drug details — trazodone hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 3
- Data quality
- 0.89
Quick answer
trazodone hydrochloride (TRAZODONE HYDROCHLORIDE) is a serotonin 2a (5-ht2a) receptor antagonist. Associated with Quantum Biopharma. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Serotonin 2a (5-HT2a) receptor antagonist
Primary target: 5-hydroxytryptamine receptor 2A
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is trazodone hydrochloride?
trazodone hydrochloride (TRAZODONE HYDROCHLORIDE) is a serotonin 2a (5-ht2a) receptor antagonist. Associated with Quantum Biopharma. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for trazodone hydrochloride?
TRAZODONE HYDROCHLORIDE is a marketed brand name for trazodone hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of trazodone hydrochloride?
trazodone hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.